Trephine
AboutSpecialtiesPricingLoading...

Copyright © 2024 Trephine. All rights reserved. The content of this site is intended for health care professionals.

TREPHINE

Terms Of UsePrivacy Policy

Nature cancerJournal Article

07 May 2025

A population-based analysis of the molecular landscape of glioma in adolescents and young adults reveals insights into gliomagenesis.

Abstract

Gliomas are a major cause of cancer-related deaths in adolescents and young adults (AYAs; ages 15-39 years).

Different molecular alterations drive gliomas in children and adults, leading to distinct biology and clinical consequences, but the implications of pediatric- versus adult-type alterations in AYAs are unknown.

Our population-based analysis of 1,456 clinically and molecularly characterized gliomas in patients aged 0-39 years addresses this gap. Pediatric-type alterations were found in 31% of AYA gliomas and conferred superior outcomes compared to adult-type alterations.

AYA low-grade gliomas with specific RAS-MAPK alterations exhibited senescence, tended to arise in different locations and were associated with superior outcomes compared to gliomas in children, suggesting different cellular origins. Hemispheric IDH-mutant, BRAF p.

V600E and FGFR-altered gliomas were associated with the risk of malignant transformation, having worse outcomes with increased age. These insights into gliomagenesis may provide a rationale for earlier intervention for certain tumors to disrupt the typical behavior, leading to improved outcomes.

COI Statement

Competing interests: The authors declare no competing interests.

References:

  • Ng, S. et al. An epidemiology report for primary central nervous system tumors in adolescents and young adults: a nationwide population-based study in France, 2008–2013. Neuro Oncol. 22, 851–863 (2020).
  • Ostrom, Q. T. et al. American Brain Tumor Association adolescent and young adult primary brain and central nervous system tumors diagnosed in the United States in 2008–2012. Neuro Oncol. 18, i1–i50 (2016).
  • Ostrom, Q. T. et al. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2015–2019. Neuro Oncol. 24, v1–v95 (2022).
  • Mupparapu, N., Brewster, L., Ostrom, K. F. & Elshahawi, S. I. Late-stage chemoenzymatic installation of hydroxy-bearing allyl moiety on the indole ring of tryptophan-containing peptides. Chemistry 28, e202104614 (2022).
  • Ostrom, Q. T. et al. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2016–2020. Neuro Oncol. 25, iv1–iv99 (2023).

Article info

Journal issue:

  • Volume: not provided
  • Issue: not provided

Doi:

10.1038/s43018-025-00962-x

More resources:

Nature Publishing Group

Full Text Sources

Paid

NCI CPTC Antibody Characterization Program

Research Materials

Free resource

NCI CPTAC Assay Portal

Miscellaneous

Free resource

Share: